We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IntelliPharmaCeutics International Inc (QB) | USOTC:IPCIF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.06 | 0.0379 | 0.10 | 0.00 | 21:00:05 |
|
|
Intellipharmaceutics
International Inc.
(Registrant)
/s/ Andrew
Patient
|
Date: April 16, 2017
|
|
Andrew Patient
Chief Financial Officer
|
Exhibit
|
Description
|
99.1
|
Proxy for Common Shares Solicited on Behalf of the Management of
Intellipharmaceutics International Inc.
|
99.2
|
Notice of 2018 Annual and Special Meeting of Shareholders and
Management Proxy Circular
|
99.3
|
Confirmation of Mailing
|
99.4
|
Voting Instruction Form
|
99.5
|
Notice-and-Access Notification to Shareholders
|
|
|
1 Year IntelliPharmaCeutics (QB) Chart |
1 Month IntelliPharmaCeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions